New research has found that Lipitor does not reduce the risk of cardiovascular problems in women leading experts to question the benefits of the drug in women.
Lipitor has been the top-selling drug in the world and has accounted for over 12 billion dollars in annual sales.
Cholesterol
Cholesterol is produced by the body (liver) and is essential for normal body functioning.
Advertisement
It has been prescribed to both men and women to lower cholesterol and reduce the risk of heart attack and stroke in patients with common risk factors for heart disease.
Now, the latest study was unable to find high quality clinical evidence documenting reduced heart attack risk for women in a primary prevention context.
![Cholesterol - The Enigma Chemical]( "Cholesterol - The Enigma Chemical")
The word 'Cholesterol' rings danger bells as soon as it is mentioned. This important chemical is important for the normal metabolism of the body and is dangerous only if present in excess.
Also, the study by Theodore Eisenberg of Cornell Law School and Martin T. Wells of Cornell University, also claims that the advertisements for the drug doesn't include label information relevant to women.
For the study, the researchers assembled studies for a meta analysis of drugs' effects on cardiovascular risk, considering all relevant studies reporting risks for both men and women.
No study including women with a mixture of risk factors for heart attacks gave any heed to the prescription of Lipitor or other statins to protect against cardiovascular problems.
Pfizer's claims of clinical proof that Lipitor reduces risk of heart attack in patients with multiple risk factors for heart disease does not appear to be scientifically supported for large segments of the female population.
Also, Lipitor's advertising repeatedly fails to report that clinical trials were statistically significant for men but not for women. Thus, unqualified advertising claims of protection against heart attacks may be misleading.
Pfizer's advertising also does not disclose critical portions of the Lipitor FDA-approved label, which acknowledges the absence of evidence with respect to women.
"Our findings indicate that each year, reasonably healthy women spend billions of dollars on drugs in the hope of preventing heart attacks but that scientific evidence supporting their hope does not exist," concluded the authors.
The study is appearing in the Journal of Empirical Legal Studies.
Source: ANI
RAS/SK
Cholesterol - The Enigma Chemical
The word 'Cholesterol' rings danger bells as soon as it is mentioned. This important chemical is important for the normal metabolism of the body and is dangerous only if present in excess.
Advertisement
Also, the study by Theodore Eisenberg of Cornell Law School and Martin T. Wells of Cornell University, also claims that the advertisements for the drug doesn't include label information relevant to women.
For the study, the researchers assembled studies for a meta analysis of drugs' effects on cardiovascular risk, considering all relevant studies reporting risks for both men and women.
No study including women with a mixture of risk factors for heart attacks gave any heed to the prescription of Lipitor or other statins to protect against cardiovascular problems.
Pfizer's claims of clinical proof that Lipitor reduces risk of heart attack in patients with multiple risk factors for heart disease does not appear to be scientifically supported for large segments of the female population.
Also, Lipitor's advertising repeatedly fails to report that clinical trials were statistically significant for men but not for women. Thus, unqualified advertising claims of protection against heart attacks may be misleading.
Pfizer's advertising also does not disclose critical portions of the Lipitor FDA-approved label, which acknowledges the absence of evidence with respect to women.
"Our findings indicate that each year, reasonably healthy women spend billions of dollars on drugs in the hope of preventing heart attacks but that scientific evidence supporting their hope does not exist," concluded the authors.
The study is appearing in the Journal of Empirical Legal Studies.
Source: ANI
RAS/SK
Animation of heart attack symptoms - Animation
Heart attack can cause symptoms such as Chest pain or discomfort, Shortness of breath and pain in neck, back, arm, or shoulder and is due to blockage of blood supply to the heart muscles
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.